Leonard Capital Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Leonard Capital Management’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-89,235	Closed	-$4.1M	–	94
2015 Q2	$4.1M	Hold	89,235	–	–	1.42%	16
2015 Q1	$4.18M	Buy	89,235 +1,574	+2%	+$62.6K	1.44%	13
2014 Q4	$2.78M	Hold	87,661	–	–	0.72%	51
2014 Q3	$2.08M	Hold	87,661	–	–	0.76%	58
2014 Q2	$2.63M	Hold	87,661	–	–	0.89%	45
2014 Q1	$2.32M	Hold	87,661	–	–	0.83%	49
2013 Q4	$2.2M	Hold	87,661	–	–	0.86%	53
2013 Q3	$1.79M	Hold	87,661	–	–	0.71%	70
2013 Q2	$1.75M	Buy	+87,661	New	+$1.56M	0.67%	69

Other funds holding IPXL

Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Leonard Capital Management's IPXL Position: Q3 2015 in Review

Leonard Capital Management sold out of Impax Laboratories, Inc. (IPXL) in Q3 2015, closing a stake of 89,235 shares — an estimated $4.1M sold.

Leonard Capital Management first reported a position in IPXL in Q2 2013 and held it in 9 quarters. The position peaked at $4.18M in Q1 2015. 195 funds tracked by Wall St. Rank hold IPXL as of Q3 2015.

Leonard Capital Management reported no remaining Impax Laboratories, Inc. position as of Q3 2015 after selling out during the quarter.
Leonard Capital Management sold 89,235 Impax Laboratories, Inc. shares in Q3 2015, an estimated $4.1M.
Leonard Capital Management first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 9 quarters.
Leonard Capital Management's Impax Laboratories, Inc. position peaked at $4.18M in Q1 2015.
195 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q3 2015.

Based on Leonard Capital Management's 13F filing for Q3 2015.